Abstract
Context:
Salivary cortisol could be a good marker for temporomandibular joint disorders. This article aimed to study the association between salivary cortisol and temporomandibular joint disorders (TMD).Methods:
PubMed, Web of Science, Scopus, and Embase were searched according to the PRISMA guidelines without restricting the publication start date until October 2022. Only case-control studies were included in the study. The critical appraisal checklist of the Joanna Briggs Institute was utilized to appraise the selected articles.Results:
Of 1173 articles found, 23 studies were eligible, and 18 were meta-analyzed. A total of 696 TMD patients and 785 controls were included. Meta-analysis showed that salivary cortisol was significantly higher in patients with TMD than the controls. Meta-regression showed that the difference in mean salivary cortisol decreased significantly between the two groups with increasing age.Conclusions:
The salivary cortisol in patients with TMD is significantly higher than in the controls. As the heterogeneity among the studies was high, more studies are required to verify this association.Keywords
Temporomandibular Joint Disorders Hydrocortisone Saliva Stress Meta-analysis
1. Context
Temporomandibular disorders (TMDs) are a diverse group of diseases that affect the temporomandibular joint (TMJ), the muscles of mastication, and related structures (1). TMD is the most prevalent chronic orofacial disorder that affects many people (2) and is more prevalent in 20- 40-year-old females (3). The most important clinical signs of TMD include joint sounds, TMJ or muscular pain, and deviations or limitations in mouth opening (4). TMD is typically characterized by pain as the main symptom, and those affected often experience frequent stress in their daily lives (2). The nature of TMD involves multiple factors, but there is debate regarding the specific factors involved (5).
Patients with TMD usually have psychological stress as a significant triggering factor (6, 7). Patients with higher stress are more inclined to bruxism and TMD (8). The significance of psychosocial factors in the etiology of TMD might suggest that these disorders are part of somatoform disorders (9). Therefore, some studies have suggested that the hypothalamic-pituitary-adrenal (HPA) axis plays a role in the pathogenesis of these disorders, and patients with TMD who have inadequate stress responses exhibit increased cortisol secretion (10). Physiological stress activates the HPA axis, which leads to the secretion of cortisol (11, 12), which is then filtered in the acinar cells of the salivary glands and released freely into the saliva (13, 14).
Plasma cortisol is a reliable means to assess the HPA axis, as is salivary cortisol (15). The main advantages of salivary cortisol over serum are the possibility of non-invasive and non-stressful sampling (16). The cause of TMD is not fully understood, but some researchers have explored a potential link between cortisol and TMD. Specifically, they have studied the relationship between salivary cortisol levels and TMD in several different studies (17-25). This systematic review examined the findings from these studies to determine whether there is a correlation between cortisol levels and TMDs.
2. Methods
This systematic review was done according to the PRISMA guidelines (26). The Regional Ethics Committee approved this study (IR.TBZMED.REC.1401.268). The main question was devised according to the “PECO” (population, exposure, comparison, and outcome) approach, where “P” is the whole population, “E” is patients with Temporomandibular joint disorders, “C” is healthy people, and “O” is salivary cortisol levels.
2.1. Eligibility Criteria
Only case-control articles published in English until February 2023 (with no restrictions on publication start dates) were included.
Studies were excluded if they were reprinted articles using information from the same sample, letters to the editor, correspondences, and papers whose full text was unavailable.
2.2. Search Strategy
Electronic research without restriction on publication start date was carried out in October 2022 using four main databases: PubMed, Web of Science, Scopus, and Embase.
All combinations of free and MESH (Medical Subject Heading) terms, including "temporomandibular joint disorders", "temporomandibular joint", "temporomandibular joint dysfunction", "temporomandibular joint disk", "temporomandibular joint disk displacement", "myofascial pain", "myofascial pain and dysfunction”, "myofascial pain disorder syndrome", "myofascial pain dysfunction", "cortisol", "cortisone", "corticosteroid", "salivary cortisol”, "serum cortisol", "blood cortisol", "serum hydrocortisone", "corticosteroid hormone", “hypothalamic pituitary adrenal axis” with “OR” and “AND” operators were searched. The exact search strategy is presented in Appendix 1 in the Supplementary File. The reference lists of the included articles were also searched to identify more papers. The EndNote Basic software was used to identify and remove duplicate references.
2.3. Screening and Selection
The titles were screened by two independent reviewers (H. E. and Z. H.) for compatibility with the research question based on the PECO, and only studies comparing salivary cortisol levels in patients with and without TMD were included. Studies using an intervention, case reports, and studies on patients with fibromyalgia-associated syndromes, sleep apnea, giant-cell arteritis, and autoimmune diseases, such as rheumatoid arthritis, were excluded. Then, the abstracts were reviewed. The authors discussed with the third reviewer (K. K.) whenever there was any disagreement. Then, the full-text articles were examined.
2.4. Data Extraction
After the final selection of studies, the required information was extracted and summarized using a table designed by the Microsoft Excel software.
The first author’s name, year of study, country of origin, type of study, gender of participants, mean age, sample size, type of saliva, and cortisol levels were obtained from the studies (when available) by two independent reviewers (K. K. and Z. H.).
2.5. Assessment of the Risk of Bias
The critical appraisal checklist for case-control studies, developed by the Joanna Briggs Institute (JBI) (27), was utilized by two evaluators (B. A. and Z. H.) independently to appraise the articles. Disagreements were resolved by consulting with the third researcher (H. E.).
2.6. Definitions
TMDs: TMDs refer to a group of clinical conditions that affect the masticatory muscles, TMJs, and related structures. These disorders are characterized by facial pain in the region of the TMJs or muscles of mastication, limitation or deviation in mandibular movements, hyperalgesia of the musculoskeletal structures, and TMJ sounds during jaw movement and function (28).
Unstimulated saliva: The saliva produced at rest, which is saliva secreted most of the day, can be collected by spitting and absorbent methods. In the spit method, the patient allows saliva to collect in the mouth and then spit into a pre-weighed tube, usually every 60 seconds for 5 to 15 minutes. The absorbent method uses a pre-weighed sponge placed in the mouth for a predetermined time. To ensure an unstimulated sample, the patient is instructed to refrain from eating, drinking, smoking, chewing gum, and oral hygiene practices or any other oral stimulation for at least 90 minutes prior to the test session. Excessive movement and talking are discouraged during the test period (29).
Stimulated saliva: Stimulation of salivation typically occurs between 10% and 20% of the day, influenced by olfactory, gustatory, and mechanical stimuli. The secretion of salivary fluid and salivary proteins is controlled by both the sympathetic and parasympathetic subsystems of the autonomic nervous system. Upon stimulation, the volume of the saliva increases, and it becomes more hypotonic and less viscous. Chewing an unflavored gum base or an inert substance, such as paraffin wax or a rubber band, at a controlled rate (usually 60 times per minute) is a reliable and repeatable method of inducing salivation. Also, 2% citric acid may be placed on the tongue at 30-second intervals (30).
2.7. Meta-analysis
The mean difference between salivary cortisol levels was calculated for the studies, which provided the required data. I2 and Q indices were used to measure the heterogeneity between the studies. Also, I2 greater than 50% was considered a significant heterogeneity. The results were combined by the random-effects model using CMA 2.0. A P < 0.05 was considered significant.
3. Results
3.1. Search Results
The electronic search in the mentioned databases produced 1173 articles. After duplicate removal, 940 articles remained, from which interventional studies (n = 495), case reports (n = 136), and studies on autoimmune diseases (n = 181), fibromyalgia-associated syndromes (n = 47), sleep apnea (n = 32), and giant-cell arteritis (n = 17) were excluded, and finally, 32 articles were sought for retrieval. Out of the remaining 32 articles, three articles had not used saliva (31-33), two had no control group (34, 35), and four had discussed other diseases in addition to TMD (18, 36-38). Twenty-three articles entered the systematic review, and 18 papers were meta-analyzed. Also, 5 articles did not provide the required data for meta-analysis (17, 39-42). The PRISMA flow diagram presents the search results in detail (Figure 1).
The PRISMA flow diagram shows the article selection process.
3.2. Assessing the Risk of Bias
Based on the JBI tool, out of 18 studies in the meta-analysis, 13 had a low risk of bias, while the remaining five studies were identified with a moderate risk of bias. (Table 1)
| Author | Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Q9 | Q10 | Total | Risk of Bias |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Da Silva Andrade et al.(43) | Y | Y | Y | Y | Y | Y | Y | Y | N | Y | 90 | Low |
| Nilsson and Dahlstrom (44) | Y | Y | Y | Y | Y | Y | Y | Y | U | Y | 90 | Low |
| Barabosa et al. (45) | Y | N | Y | Y | Y | Y | Y | Y | U | Y | 80 | Low |
| De Almeida et al. (46) | Y | N | Y | Y | Y | N | N | Y | N | Y | 60 | Moderate |
| Kobayashi et al. (20) | Y | Y | Y | Y | Y | N | N | Y | U | Y | 70 | Low |
| Venkatesh et al. (25) | Y | Y | Y | Y | Y | Y | U | Y | U | Y | 80 | Low |
| Jasim et al. (47) | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | 100 | Low |
| Nadendla et al. (21) | Y | Y | Y | Y | Y | Y | N | Y | U | Y | 80 | Low |
| Salameh et al. (24) | Y | Y | Y | Y | Y | Y | N | Y | U | Y | 80 | Low |
| Poorian et al. (22) | Y | U | Y | U | Y | N | N | Y | U | Y | 50 | Moderate |
| Galvão-Moreira et al. (48) | Y | N | Y | Y | Y | Y | Y | Y | Y | Y | 90 | Low |
| Vrbanovic et al. (49) | Y | Y | Y | Y | Y | N | N | Y | Y | Y | 80 | Low |
| Chinthakanan et al. (19) | Y | N | Y | Y | Y | N | N | Y | U | Y | 60 | Moderate |
| Staniszewski et al. (50) | Y | Y | Y | Y | Y | N | N | Y | U | Y | 70 | Low |
| Alresayes et al. (51) | Y | U | Y | Y | Y | Y | N | Y | U | Y | 70 | Low |
| Barakian et al. (52) | Y | U | Y | U | U | N | N | Y | Y | Y | 50 | Moderate |
| Goyal et al. (53) | Y | Y | Y | Y | Y | Y | Y | Y | U | Y | 90 | Low |
| Cheon et al. (23) | Y | N | Y | Y | Y | N | N | Y | U | Y | 60 | Moderate |
3.3. Characteristics of the Studies
Some studies collected stimulated saliva (20, 25, 43-46), while others collected unstimulated saliva (19, 21-24, 47-53). Table 2 shows the included studies' descriptive characteristics and related data. Overall, 1467 participants were examined in these 18 studies. The publication date of studies ranged from 2008 to 2022.
| Author | Country | Sex (Female %) | Participants’ Age (year) in the Case/ Control Group | Sample Size in the Case/ Control Group | Type of Saliva | Cortisol Levels (µg/dL) in the Case Group (Mean ± SD) | Cortisol Levels (µg/dL) in the Control Group (Mean ± SD) |
|---|---|---|---|---|---|---|---|
| Da Silva Andrade et al. (43) | Brazil | 50 | 22.5/22.8 | 20/20 | Stimulated | 0.27 ± 0.10 | 0.39 ± 0.33 |
| Nilsson and Dahlstrom (44) | Sweden | 100 | 19.7/21.2 | 30/30 | Stimulated | 0.41 ± 0.24 | 0.49 ± 0.36 |
| Barabosa (45) | Brazil | 66 | 11/11 | 86/59 | Stimulated | 0.21 ± 0.16 | 0.16 ± 0.12 |
| De Almeida et al. (46) | Brazil | 75 | 21.8/21.2 | 25/23 | Stimulated | 0.27 ± 0.2 | 0.39 ± 0.33 |
| Kobayashi et al. (20) | Brazil | 63 | 10.6/10.6 | 38/38 | Stimulated | 0.15 ± 0.09 | 0.15 ± 0.09 |
| Venkatesh et al. (25) | India | 53 | 20.5/20.5 | 107/241 | Stimulated | 1.10 ± 0.17 | 0.69 ± 0.16 |
| Jasim et al. (47) | Sweden | 100 | 42.3/45.7 | 27/27 | Unstimulated | 0.20 ± 0.26 | 0.21 ± 0.14 |
| Nadendla et al. (21) | India | 55 | 36.6/36.6 | 20/20 | Unstimulated | 1.7 ± 0.29 | 0.53 ± 0.13 |
| Salameh et al. (24) | Syria | 70 | 29.1/29.1 | 60/60 | Unstimulated | 0.21 ± 0.13 | 0.07 ± 0.04 |
| Poorian et al. (22) | Iran | 54 | 32.4/39.6 | 15/60 | Unstimulated | 2.90 ± 0.52 | 0.88 ± 0.95 |
| Galvão-Moreira et al. (48) | Brazil | 64 | 28.5/28.5 | 39/33 | Unstimulated | 0.10 ± 0.04 | 0.084 ± 0.04 |
| Vrbanovic et al. (49) | Croatia | 100 | 39.3/34.3 | 20/15 | Unstimulated | 0.41 ± 0.28 | 0.24 ± 0.16 |
| Chinthakanan et al. (19) | Thailand | 72 | 22/26.0 | 23/21 | Unstimulated | 0.29 ± 0.12 | 0.22 ± 0.06 |
| Staniszewski et al. (50) | Norway | 86 | 44/46 | 44/44 | Unstimulated | 0.26 ± 0.22 | 0.17 ± 0.13 |
| Alresayes et al. (51) | Saudi Arabia | 88 | 16.3/16.5 | 18/18 | Unstimulated | 0.31 ± 0.03 | 0.05 ± 0.00 |
| Barakian et al. (52) | Iran | NR | NR | 24/36 | Unstimulated | 0.49 ± 0.37 | 0.45 ± 0.20 |
| Goyal et al. (53) | India | 50 | 25.5/23.6 | 40/20 | Unstimulated | 0.36 ± 0.22 | 0.12 ± 0.42 |
| Cheon et al. (23) | Korea | 50 | 28.2/25.9 | 32/34 | Unstimulated | 0.2 ± 0.12 | 0.11 ± 0.03 |
3.4. Meta-analysis
The difference between mean salivary cortisol in the case and control groups:
The mean age of 668 participants in the case group was 26.49, and of 799 participants in the control group was 27.03 years. The lack of homogeneity between studies was significant (Q-value = 354.24, df = 17, I-squared = 95.20, and P-value < 0.001). Meta-analysis with the random-effects model indicated that the salivary cortisol in the case group was 0.178 units higher, which was statistically significant (pooled mean difference = 0.178, SD = 0.043, 95% CI = 0.262 - 0.094, z-value = 4.163, and P-value < 0.001). Figure 2 depicts the forest plot of this meta-analysis.
The forest plot depicting the included studies in the present meta-analysis.
The difference in mean salivary cortisol between study groups based on the type of saliva:
Six studies used stimulated saliva, while 12 used unstimulated saliva. The intragroup difference in the pooled mean salivary cortisol was 0.030 units for stimulated saliva and 0.251 units for unstimulated saliva. This difference was not statistically significant for stimulated saliva but significant for unstimulated saliva. Figure 3 and Table 3 show the results of the subgroup analysis.
The forest plot of subgroups categorized according to the type of saliva collection method
The Results of the Meta-analysis in Subgroups
| Groups | Effect Size and 95% Confidence Interval | Test of the Null Hypothesis (2-Tail) | Heterogeneity | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Studies | Point Estimate | Standard Error | Lower Limit | Upper Limit | Z-Value | P-Value | Q-Value | df (Q) | P-Value | I-Squared | |
| Stimulated saliva | 6 | 0.03 | 0.10 | -0.17 | 0.23 | 0.30 | 0.76 | 291.13 | 5 | 0 | 98.28 |
| Unstimulated saliva | 12 | 0.25 | 0.05 | 0.15 | 0.35 | 4.83 | 0.00 | 687.96 | 11 | 0 | 98.40 |
3.5. Meta-regression Results Based on Age
Meta-regression was used to explore the effect of age on the mean difference in salivary cortisol in the case and control groups. With increasing age in the studied subjects, the difference in mean salivary cortisol amongst the two groups decreased by 0.006 units, which was statistically significant (regression slope = -0.006, 95% CI =- 0.0077; -0.0052), P-value < 0.001). Figure 4 shows the meta-regression results.
The meta-regression for age in the included articles.
3.6. Publication Bias
The Funnel plot of publication bias is presented in Figure 5. Based on the symmetry in the diagram, there is no publication bias. Also, based on the results of the Egger regression test, the publication bias was not statistically significant (t-value = 0.255, df = 16, and P-value = 0.80).
The Funnel plot of publication bias
4. Discussion
According to the results of this systematic review, individuals with TMD exhibited significantly higher salivary cortisol levels compared to the control groups. Salivary cortisol is frequently utilized in research due to its simple collection process and low cost. However, cortisol levels can be affected by the time of collection (54); therefore, only morning cortisol levels were taken into account for this meta-analysis.
In 6 articles that studied stimulated saliva, there was no significant association between the salivary levels of TMD patients and controls, although there were some contradictory results between the studies. Venkatesh et al. showed a significant correlation between salivary cortisol levels and TMD. They suggested that salivary cortisol could be a useful marker to assess the severity of TMD in individuals who experience stress (25). Additionally, Da Silva Andrade et al. showed that females with TMD had higher cortisol levels than the control group; however, there was no significant difference between the two groups in general (43). This could be because males and females respond differently to stress. It is worth noting that in most of these studies, the female-to-male ratio was over 50%, and three studies only included females (44, 47, 49).
In the articles that used unstimulated saliva, salivary cortisol was significantly higher in TMD patients in comparison with controls, although there were inconsistencies between the studies. The differences in the studies could be due to varying types of pain, duration of disease, and study population. Jasim et al. conducted research on salivary cortisol levels in cases of chronic and acute orofacial pain and compared it to a control group consisting of only female patients. The results showed that salivary cortisol levels were not significantly different between the three groups (47). However, Chinthakanan et al. studied TMD patients of both genders who had experienced TMD pain for at least three months. They reported that salivary cortisol levels in the TMD group did not correlate with the visual analog scale (VAS) score (19). This finding is consistent with that of Kobayashi et al., who demonstrated that salivary cortisol levels are not correlated with mild TMD pain, but there is a positive correlation between moderate and severe TMD pain and salivary cortisol levels (20). The pain intensity in the TMD group in the study by Chinthakanan et al. (19) was mild to moderate; hence, no correlation was found between pain and salivary cortisol levels. Thus, it is suggested that salivary cortisol levels are associated with the severity of pain.
The possible explanation is a relationship between the severe pain experienced by the patients and an increase in stress psychobiology, including anxiety and depression. Anxiety can lead to an imbalance of the HPA, and cortisol is the major factor associated with the HPA imbalance (55).
The duration of the TMD could explain why the study results differed. In the study by Vrbanovic et al., patients had experienced pain lasting more than six months (49); therefore, higher cortisol might imply a compensatory increase in the function of the HPA axis. Some articles did not report how long their patients experienced TMD pain.
One of the most frequently suggested mechanisms causing myofascial pain associated with TMDs is hyperactivity of the masticatory muscles (56). When exposed to stress, some patients respond with increased masticatory muscle activity rather than a general increase in body muscle tonus. Such activity manifested as parafunctional habits, can result in muscular fatigue and spasms, leading to myofascial pain and TMD (57).
Bozovic et al. examined 30 university students with myofascial pain and 30 healthy students and found that salivary cortisol levels were higher in students with myofascial pain on both exam days and typical days compared to the control group. Additionally, the salivary cortisol level was found to correlate with psychological factors in students with TMD but not in the control group (17). These findings suggest that preexisting vulnerability, such as TMD, can cause an increase in salivary cortisol levels on stressful days in students with TMD.
As shown in Table 2, the salivary cortisol levels in both stimulated and unstimulated saliva were in a similar range. In general, the concentrations of salivary components that are actively transported, like cortisol, are not significantly reduced in stimulated saliva; however, the concentration of proteins that are not actively transported will tend to decrease in stimulated compared to unstimulated saliva (58).
Higher salivary cortisol levels in TMD patients indicate that stress, either with a role in the development of TMD or pain-related TMD, produces additional stress to the body and further enhances cortisol secretion. For a definite conclusion, longitudinal prospective studies are needed.
Three articles (20, 45, 51) studied children and adolescents, while the others studied adults, which is one of the limitations of this systematic review. Females have higher salivary cortisol levels than men; therefore, gender distribution plays an important role. Seven studies (22, 25, 45-, 51, 52) failed to provide the same female-to-male ratio between the groups, which might contribute to the heterogeneity of the results.
5. Conclusions
This study showed that individuals with TMD have higher cortisol levels in their saliva than those without TMD. This could be due to stress, anxiety, and depression. It is recommended that psychological support be included in the treatment plan for TMD. However, as there are variations in the findings of different studies, further research with a larger sample size and a prospective design would help gain more insight into this issue.
Acknowledgements
References
-
1.
Rokaya D, Suttagul K, Joshi S, Bhattarai BP, Shah PK, Dixit S. An epidemiological study on the prevalence of temporomandibular disorder and associated history and problems in Nepalese subjects. J Dent Anesth Pain Med. 2018;18(1):27-33. [PubMed ID: 29556556]. [PubMed Central ID: PMC5858007]. https://doi.org/10.17245/jdapm.2018.18.1.27.
-
2.
Shueb SS, Nixdorf DR, John MT, Alonso BF, Durham J. What is the impact of acute and chronic orofacial pain on quality of life? J Dent. 2015;43(10):1203-10. [PubMed ID: 26073033]. https://doi.org/10.1016/j.jdent.2015.06.001.
-
3.
Silva FCD, Oliveira TM, Almeida A, Bastos RDS, Neppelenbroek KH, Soares S. Impact of Temporomandibular Disorders and Sleep Bruxism on Oral Health-Related Quality of Life of Individuals With Complete Cleft Lip and Palate. J Craniofac Surg. 2018;29(6):1505-8. [PubMed ID: 30074958]. https://doi.org/10.1097/SCS.0000000000004723.
-
4.
Manfredini D, Guarda-Nardini L, Winocur E, Piccotti F, Ahlberg J, Lobbezoo F. Research diagnostic criteria for temporomandibular disorders: a systematic review of axis I epidemiologic findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112(4):453-62. [PubMed ID: 21835653]. https://doi.org/10.1016/j.tripleo.2011.04.021.
-
5.
Kudagi VS, Jaishankar HP, Raghunath N, Shivakumar S, Deshpande PS, Bhagyalakshmi A, et al. Temporomandibular Disorders and Its Management in Dentistry: A Review. Indian J Public Health Res Dev. 2021;12(4):424-9.
-
6.
Wu G, Chen L, Zhu G, Su Y, Chen Y, Sun J, et al. Psychological stress induces alterations in temporomandibular joint ultrastructure in a rat model of temporomandibular disorder. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112(6):e106-12. [PubMed ID: 21906974]. https://doi.org/10.1016/j.tripleo.2011.06.005.
-
7.
Burke NN, Finn DP, McGuire BE, Roche M. Psychological stress in early life as a predisposing factor for the development of chronic pain: Clinical and preclinical evidence and neurobiological mechanisms. J Neurosci Res. 2017;95(6):1257-70. [PubMed ID: 27402412]. https://doi.org/10.1002/jnr.23802.
-
8.
Luther F, Layton S, McDonald F. Orthodontics for treating temporomandibular joint (TMJ) disorders. Cochrane Database Syst Rev. 2010;(7). CD006541. [PubMed ID: 20614447]. https://doi.org/10.1002/14651858.CD006541.pub2.
-
9.
Fantoni F, Salvetti G, Manfredini D, Bosco M. Current concepts on the functional somatic syndromes and temporomandibular disorders. Stomatologija. 2007;9(1):3-9. [PubMed ID: 17449972].
-
10.
Yang D, Ye L. Temporomandibular disorders and declarative memory. Med Hypotheses. 2011;76(5):723-5. [PubMed ID: 21354714]. https://doi.org/10.1016/j.mehy.2011.02.007.
-
11.
Kumsta R, Entringer S, Hellhammer DH, Wust S. Cortisol and ACTH responses to psychosocial stress are modulated by corticosteroid binding globulin levels. Psychoneuroendocrinology. 2007;32(8-10):1153-7. [PubMed ID: 17904296]. https://doi.org/10.1016/j.psyneuen.2007.08.007.
-
12.
Yoshihara T, Shigeta K, Hasegawa H, Ishitani N, Masumoto Y, Yamasaki Y. Neuroendocrine responses to psychological stress in patients with myofascial pain. J Orofac Pain. 2005;19(3):202-8. [PubMed ID: 16106713].
-
13.
Heikenfeld J, Jajack A, Feldman B, Granger SW, Gaitonde S, Begtrup G, et al. Accessing analytes in biofluids for peripheral biochemical monitoring. Nat Biotechnol. 2019;37(4):407-19. [PubMed ID: 30804536]. https://doi.org/10.1038/s41587-019-0040-3.
-
14.
Safarzadeh E, Mostafavi F, Ashtiani MH. Determination of salivary cortisol in healthy children and adolescents. Acta Medica Iranica. 2005:32-6.
-
15.
Langelaan MLP, Kisters JMH, Oosterwerff MM, Boer AK. Salivary cortisol in the diagnosis of adrenal insufficiency: cost efficient and patient friendly. Endocr Connect. 2018;7(4):560-6. [PubMed ID: 29531158]. [PubMed Central ID: PMC5890080]. https://doi.org/10.1530/EC-18-0085.
-
16.
Weibel L. [Methodological guidelines for the use of salivary cortisol as biological marker of stress]. Presse Med. 2003;32(18):845-51. French. [PubMed ID: 12870390].
-
17.
Bozovic D, Ivkovic N, Racic M, Ristic S. Salivary cortisol responses to acute stress in students with myofascial pain. Srp Arh Celok Lek. 2018;146(1-2):20-5. https://doi.org/10.2298/sarh161221172b.
-
18.
Rosar JV, Barbosa TS, Dias IOV, Kobayashi FY, Costa YM, Gaviao MBD, et al. Effect of interocclusal appliance on bite force, sleep quality, salivary cortisol levels and signs and symptoms of temporomandibular dysfunction in adults with sleep bruxism. Arch Oral Biol. 2017;82:62-70. [PubMed ID: 28601734]. https://doi.org/10.1016/j.archoralbio.2017.05.018.
-
19.
Chinthakanan S, Laosuwan K, Boonyawong P, Kumfu S, Chattipakorn N, Chattipakorn SC. Reduced heart rate variability and increased saliva cortisol in patients with TMD. Arch Oral Biol. 2018;90:125-9. [PubMed ID: 29604544]. https://doi.org/10.1016/j.archoralbio.2018.03.011.
-
20.
Kobayashi FY, Gaviao MBD, Marquezin MCS, Fonseca FLA, Montes ABM, Barbosa TS, et al. Salivary stress biomarkers and anxiety symptoms in children with and without temporomandibular disorders. Braz Oral Res. 2017;31. e78. [PubMed ID: 29019550]. https://doi.org/10.1590/1807-3107BOR-2017.vol31.0078.
-
21.
Nadendla LK, Meduri V, Paramkusam G, Pachava KR. Evaluation of salivary cortisol and anxiety levels in myofascial pain dysfunction syndrome. Korean J Pain. 2014;27(1):30-4. [PubMed ID: 24478898]. [PubMed Central ID: PMC3903798]. https://doi.org/10.3344/kjp.2014.27.1.30.
-
22.
Poorian B, Dehghani N, Bemanali M. Comparison of Salivary Cortisol Level in Temporomandibular Disorders and Healthy People. Int J Rev Life Sci. 2015;5(10):1105-13.
-
23.
Cheon C, Park H, Ryu J, Ahn J. Comparative Analysis of Salivary Cortisol in Young Adult Patients with Temporomandibular Disorders. J Oral Med Pain. 2022;47(4):183-8. https://doi.org/10.14476/jomp.2022.47.4.183.
-
24.
Salameh E, Alshaarani F, Hamed HA, Nassar JA. Investigation of the relationship between psychosocial stress and temporomandibular disorder in adults by measuring salivary cortisol concentration: A case-control study. J Indian Prosthodont Soc. 2015;15(2):148-52. [PubMed ID: 26929502]. [PubMed Central ID: PMC4762310]. https://doi.org/10.4103/0972-4052.158075.
-
25.
Venkatesh SB, Shetty SS, Kamath V. Prevalence of Temporomandibular Disorders and its Correlation with Stress and Salivary Cortisol Levels among Students. Pesqui Bras Odontopediatria Clin Integr. 2021;21. https://doi.org/10.1590/pboci.2021.029.
-
26.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. [PubMed ID: 19622552]. [PubMed Central ID: PMC2714672]. https://doi.org/10.1136/bmj.b2700.
-
27.
Porritt K, Gomersall J, Lockwood C. JBI's Systematic Reviews: Study selection and critical appraisal. Am J Nurs. 2014;114(6):47-52. [PubMed ID: 24869584]. https://doi.org/10.1097/01.NAJ.0000450430.97383.64.
-
28.
List T, Jensen RH. Temporomandibular disorders: Old ideas and new concepts. Cephalalgia. 2017;37(7):692-704. [PubMed ID: 28068790]. https://doi.org/10.1177/0333102416686302.
-
29.
Bellagambi FG, Lomonaco T, Salvo P, Vivaldi F, Hangouët M, Ghimenti S, et al. Saliva sampling: Methods and devices. An overview. TrAC Trends Anal Chem. 2020;124:115781. https://doi.org/10.1016/j.trac.2019.115781.
-
30.
Jasim H, Carlsson A, Hedenberg-Magnusson B, Ghafouri B, Ernberg M. Saliva as a medium to detect and measure biomarkers related to pain. Sci Rep. 2018;8(1):3220. [PubMed ID: 29459715]. [PubMed Central ID: PMC5818517]. https://doi.org/10.1038/s41598-018-21131-4.
-
31.
Korszun A, Young EA, Singer K, Carlson NE, Brown MB, Crofford L. Basal circadian cortisol secretion in women with temporomandibular disorders. J Dent Res. 2002;81(4):279-83. [PubMed ID: 12097314]. https://doi.org/10.1177/154405910208100411.
-
32.
Lambert CA, Sanders A, Wilder RS, Slade GD, Van Uum S, Russell E, et al. Chronic HPA axis response to stress in temporomandibular disorder. J Dent Hyg. 2014;88 Suppl 1(Suppl 1):5-12. [PubMed ID: 25071145]. [PubMed Central ID: PMC4987539].
-
33.
Lin SL, Wu SL, Tsai CC, Ko SY, Yang JW. Serum cortisol level and disc displacement disorders of the temporomandibular joint. J Oral Rehabil. 2016;43(1):10-5. [PubMed ID: 26205185]. https://doi.org/10.1111/joor.12331.
-
34.
Doepel M, Soderling E, Ekberg EL, Nilner M, Le Bell Y. Salivary cortisol and IgA levels in patients with myofascial pain treated with occlusal appliances in the short term. J Oral Rehabil. 2009;36(3):210-6. [PubMed ID: 19054288]. https://doi.org/10.1111/j.1365-2842.2008.01923.x.
-
35.
Laccio KJD, Colato AS, Dorneles GP, Peres A. Assessment of Levels of Salivary Cortisol and Stress in Patients with Signs and Symptoms of Temporomandibular Joint Disorders. Int J Health Sci. 2014;2(4). https://doi.org/10.15640/ijhs.v2n4a5.
-
36.
Khayamzadeh M, Mirzaii-Dizgah I, Aghababainejad P, Habibzadeh S, Kharazifard MJ. Relationship between Parafunctional Habits and Salivary Biomarkers. Front Dent. 2019;16(6):465-72. [PubMed ID: 33089248]. [PubMed Central ID: PMC7569274]. https://doi.org/10.18502/fid.v16i6.3446.
-
37.
Ali SQ, Hadi R. An Assessment of Alpha-Amylase as Salivary Psychological Stress Marker in Relation to Temporomandibular Disorders among a Sample of Dental Students. J Baghdad Coll Dent. 2015;325(3129):1-6.
-
38.
Fluerasu MI, Bocsan IC, Buduru S, Pop RM, Vesa SC, Zaharia A, et al. The correlation between sleep bruxism, salivary cortisol, and psychological status in young, Caucasian healthy adults. Cranio. 2021;39(3):218-24. [PubMed ID: 31131730]. https://doi.org/10.1080/08869634.2019.1619250.
-
39.
Suprajith T, Wali A, Jain A, Patil K, Mahale P, Niranjan V. Effect of Temporomandibular Disorders on Cortisol Concentration in the Body and Treatment with Occlusal Equilibrium. J Pharm Bioallied Sci. 2022;14(Suppl 1):S483-5. [PubMed ID: 36110674]. [PubMed Central ID: PMC9469300]. https://doi.org/10.4103/jpbs.jpbs_867_21.
-
40.
Jones DA, Rollman GB, Brooke RI. The cortisol response to psychological stress in temporomandibular dysfunction. Pain. 1997;72(1-2):171-82. [PubMed ID: 9272801]. https://doi.org/10.1016/s0304-3959(97)00035-3.
-
41.
Quartana PJ, Buenaver LF, Edwards RR, Klick B, Haythornthwaite JA, Smith MT. Pain catastrophizing and salivary cortisol responses to laboratory pain testing in temporomandibular disorder and healthy participants. J Pain. 2010;11(2):186-94. [PubMed ID: 19853521]. [PubMed Central ID: PMC2821973]. https://doi.org/10.1016/j.jpain.2009.07.008.
-
42.
Jo KB, Lee YJ, Lee IG, Lee SC, Park JY, Ahn RS. Association of pain intensity, pain-related disability, and depression with hypothalamus-pituitary-adrenal axis function in female patients with chronic temporomandibular disorders. Psychoneuroendocrinology. 2016;69:106-15. [PubMed ID: 27082645]. https://doi.org/10.1016/j.psyneuen.2016.03.017.
-
43.
Da Silva Andrade A, Gamero GH, Pereira LJ, Junqueira Zanin IC, Gaviao MB. Salivary cortisol levels in young adults with temporomandibular disorders. Minerva Stomatol. 2008;57(3):109-16. [PubMed ID: 18427379].
-
44.
Nilsson AM, Dahlstrom L. Perceived symptoms of psychological distress and salivary cortisol levels in young women with muscular or disk-related temporomandibular disorders. Acta Odontol Scand. 2010;68(5):284-8. [PubMed ID: 20500119]. https://doi.org/10.3109/00016357.2010.494620.
-
45.
Barbosa TS, Castelo PM, Leme MS, Gaviao MB. Associations between oral health-related quality of life and emotional statuses in children and preadolescents. Oral Dis. 2012;18(7):639-47. [PubMed ID: 22380489]. https://doi.org/10.1111/j.1601-0825.2012.01914.x.
-
46.
De Almeida C, Paludo A, Stechman-eto J, Amenábar JM. Saliva cortisol levels and depression in individuals with temporomandibular disorder: Preliminary study. Revista Dor. 2014;15(3). https://doi.org/10.5935/1806-0013.20140037.
-
47.
Jasim H, Louca S, Christidis N, Ernberg M. Salivary cortisol and psychological factors in women with chronic and acute oro-facial pain. J Oral Rehabil. 2014;41(2):122-32. [PubMed ID: 24313837]. https://doi.org/10.1111/joor.12118.
-
48.
Galvão-Moreira LV, Andrade CMD, Oliveira JFFD, Monteiro SG, Figueiredo PDMS, Branco-de-Almeida LS. Morning salivary cortisol with regard to gender in individuals with perceived facial pain. Revista Dor. 2016;17(4):248-53. https://doi.org/10.5935/1806-0013.20160082.
-
49.
Vrbanovic E, Alajbeg IZ, Vuletic L, Lapic I, Rogic D, Andabak Rogulj A, et al. Salivary Oxidant/Antioxidant Status in Chronic Temporomandibular Disorders Is Dependent on Source and Intensity of Pain - A Pilot Study. Front Physiol. 2018;9:1405. [PubMed ID: 30386251]. [PubMed Central ID: PMC6199384]. https://doi.org/10.3389/fphys.2018.01405.
-
50.
Staniszewski K, Lygre H, Bifulco E, Kvinnsland S, Willassen L, Helgeland E, et al. Temporomandibular Disorders Related to Stress and HPA-Axis Regulation. Pain Res Manag. 2018;2018:7020751. [PubMed ID: 29854038]. [PubMed Central ID: PMC5954859]. https://doi.org/10.1155/2018/7020751.
-
51.
Alresayes S, Al-Aali K, Javed F, Alghamdi O, Mokeem SA, Vohra F, et al. Assessment of self-rated pain perception and whole salivary cortisol levels among adolescents with and without temporomandibular disorders. Cranio. 2021:1-7. [PubMed ID: 33764284]. https://doi.org/10.1080/08869634.2021.1899697.
-
52.
Barakian Y, Hajisadeghi S, Keykha E, Mohammadbeigi A, Karimi A. Investigation of the Relationship Between Occupational Stress and Temporomandibular Joint Disorders by Measuring Salivary Cortisol and Immunoglobulin a Levels in Students of Qom Dental School. Preprint. Research Square. 2021:1-9. https://doi.org/10.21203/rs.3.rs-440266/v1.
-
53.
Goyal G, Gupta D, Pallagatti S. Salivary cortisol could be a promising tool in the diagnosis of temporomandibular disorders associated with psychological factors. J Indian Acad Oral Med Radiol. 2020;32(4):354. https://doi.org/10.4103/jiaomr.jiaomr_83_20.
-
54.
Gunnar MR, Vazquez DM. Low cortisol and a flattening of expected daytime rhythm: potential indices of risk in human development. Dev Psychopathol. 2001;13(3):515-38. [PubMed ID: 11523846]. https://doi.org/10.1017/s0954579401003066.
-
55.
Zankert S, Bellingrath S, Wust S, Kudielka BM. HPA axis responses to psychological challenge linking stress and disease: What do we know on sources of intra- and interindividual variability? Psychoneuroendocrinology. 2019;105:86-97. [PubMed ID: 30390966]. https://doi.org/10.1016/j.psyneuen.2018.10.027.
-
56.
Sh OS, Bakaev JN, Safarovа MJ. Aspects of the formation of pain syndrome in the area of the masticatory muscles in the disease of the maxillary-mandibular composition. Int J Hum Comput Stud. 2021;3(1):117-21.
-
57.
Karkazi F, Ozdemir F. Temporomandibular Disorders: Fundamental Questions and Answers. Turk J Orthod. 2020;33(4):246-52. [PubMed ID: 33447468]. [PubMed Central ID: PMC7771295]. https://doi.org/10.5152/TurkJOrthod.2020.20031.
-
58.
Pedersen AML, Sorensen CE, Proctor GB, Carpenter GH, Ekstrom J. Salivary secretion in health and disease. J Oral Rehabil. 2018;45(9):730-46. [PubMed ID: 29878444]. https://doi.org/10.1111/joor.12664.